Physician

Jacob Samuel Witt, M.D.

According to 2025 Medicare claims, Jacob Witt, M.D. (NPI: 1891157871) practices radiation oncology in the St. Louis, MO-IL market, with the plurality of this provider's patient population coming from Madison, IL. This provider's primary affiliated billing organization is CANCER CARE SPECIALISTS OF CENTRAL ILLINOIS, S.C. (NPI: 1871580142; TIN: 371160364) and primary practice location at 62269-1887. Witt is affiliated with the Mercy Health Corporation (ACO ID: A2097), IRCCO (ACO ID: A2619), SSM IL ACO, LLC (ACO ID: A4832), and IHCI ACO Midwest LLC (ACO ID: A5516), participating under the MSSP model.

Witt's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 256 traditional Medicare patients, billed 11,139 HCPCS/CPT codes, and received $542,919 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 372 prescription claims across 118 beneficiaries totaling $4,833 in drug costs, led by Tamsulosin Hcl (Tamsulosin Hcl). Open Payments data shows 123 records totaling $2,511. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $3,334 to $542,919. Similarly, Part D prescription costs have risen steadily, from $361 to $4,833. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	33	69	$3,334
2021	55	888	$54,872
2022	107	2,641	$156,819
2023	132	5,434	$163,081
2024	256	11,139	$542,919

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	N/R	N/R
2016	11	30	$361
2017	27	59	$1,741
2018	36	58	$1,548
2019	44	73	$1,426
2020	29	47	$766
2021	40	76	$1,342
2022	65	158	$2,264
2023	74	212	$3,714
2024	118	372	$4,833

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	92	92	$141
77263	Complex radiation therapy planning	110	117	$129
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	117	189	$47
77300	Calculation of radiation therapy dose	110	406	$25
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	118	141	$13

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Tamsulosin Hcl	Tamsulosin Hcl	60	3,836	$548
Mometasone Furoate	Mometasone Furoate	22	590	$476
Lidocaine Hcl Viscous	Lidocaine Hcl	46	282	$435
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	30	248	$421
Dexamethasone	Dexamethasone	34	502	$282

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	123	$2,511	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Jacob Samuel Witt, M.D.?

Tedicare shows public-source Medicare data for Jacob Samuel Witt, M.D. (NPI 1891157871), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jacob Samuel Witt, M.D. have ACO affiliation data?

Jacob Samuel Witt, M.D. is shown with ACO affiliation data for Mercy Health Corporation (MSSP, ACO ID A2097), IRCCO (MSSP, ACO ID A2619), SSM IL ACO, LLC (MSSP, ACO ID A4832), and IHCI ACO Midwest LLC (MSSP, ACO ID A5516).

What billing organization is linked to Jacob Samuel Witt, M.D.?

Jacob Samuel Witt, M.D. is linked to CANCER CARE SPECIALISTS OF CENTRAL ILLINOIS, S.C. (billing NPI 1871580142) in the available physician profile data.

Does Jacob Samuel Witt, M.D. have Open Payments data?

Jacob Samuel Witt, M.D. has 123 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.